Human in vivo studies on the non-glycaemic effects of thiazolidinedione derivatives

Contains fulltext : 132629.pdf (publisher's version ) (Open Access)Radboud Universiteit Nijmegen, 18 december 2014Promotores : Smits, P., Tack, C.J.J

Duration of clopidogrel therapy with drug-eluting stents.

Contains fulltext : 88811.pdf (publisher's version ) (Open Access

Rosiglitazone reduces ischaemia-reperfusion injury in patients with the metabolic syndrome.

Contains fulltext : 89356.pdf (publisher's version ) (Open Access)01 april 201

[Iron supplementation in iron deficiency anaemia]

Iron deficiency anaemia is a common problem. The majority of patients are treated with oral iron supplements. The current recommended dosage for oral supplementation of 200 mg ferrous fumarate 3x per day however, is based on a single small study of poor quality. There is no consensus concerning parenteral dosing. In recent years, new insights have been gained regarding both the dosage of oral supplementation and the indication for parenteral supplementation. Oral therapy is preferred. In principle, 100 mg ferrous fumarate once a day is sufficient for the treatment of symptom-free patients with anaemia. In cases of severe anaemia, or in patients with symptoms, 200 mg/day should be prescribed. If side effects appear, it can be dosed every other day. Where oral therapy does not show effectiveness, the anaemia is severe, or rapid increase of haemoglobin is indicated, parenteral supplementation should be chosen. Parenteral supplementation is more effective than oral supplementation in specific conditions, such as dialysis-dependent renal insufficiency, heart failure or active IBD

[Iron supplementation in iron deficiency anaemia]

Item does not contain fulltextIron deficiency anaemia is a common problem. The majority of patients are treated with oral iron supplements. The current recommended dosage for oral supplementation of 200 mg ferrous fumarate 3x per day however, is based on a single small study of poor quality. There is no consensus concerning parenteral dosing. In recent years, new insights have been gained regarding both the dosage of oral supplementation and the indication for parenteral supplementation. Oral therapy is preferred. In principle, 100 mg ferrous fumarate once a day is sufficient for the treatment of symptom-free patients with anaemia. In cases of severe anaemia, or in patients with symptoms, 200 mg/day should be prescribed. If side effects appear, it can be dosed every other day. Where oral therapy does not show effectiveness, the anaemia is severe, or rapid increase of haemoglobin is indicated, parenteral supplementation should be chosen. Parenteral supplementation is more effective than oral supplementation in specific conditions, such as dialysis-dependent renal insufficiency, heart failure or active IBD

Drug-related problems in a clinical setting: a literature review and cross-sectional study evaluating factors to identify patients at risk

Item does not contain fulltex

Preserved response to diuretics in rosiglitazone-treated subjects with insulin resistance: a randomized double-blind placebo-controlled crossover study

Contains fulltext : 92219.pdf (publisher's version ) (Closed access

Dikke maatjes met diazoxide.

Item does not contain fulltex